China Money Network
Login
Join

Ally Bridge Leads $25M Series B In Hua Medicine

  • January 9, 2015 — 19:23 CST

This Data Is Locked!

This area is available only to Subscribers.

Shanghai-based drug developer Hua Medicine has received US$25 million series B financing led by Hong Kong and U.S.-based healthcare investment firm Ally Bridge Group, according... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: